CD19 and precursor B-cell acute lymphoblastic leukemia: In some B-ALL patients, alternative splicing of exon 2 eliminates full-length CD19 and the expression of exon 2 isoform, resulting in a protein that is not recognized by CD19 CAR-T cells and does not activate them (23, 24).